2004
DOI: 10.1016/j.radonc.2003.10.004
|View full text |Cite
|
Sign up to set email alerts
|

3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
25
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(30 citation statements)
references
References 29 publications
3
25
2
Order By: Relevance
“…High-dose-rate (HDR) prostate brachytherapy in combination with external beam radiotherapy has been reported in several series with mature followup as a safe and highly effective therapy for localized adenocarcinoma of the prostate (1)(2)(3)(4)(5)(6). The outcomes of HDR brachytherapy are particularly impressive compared to outcomes of external beam radiation alone for patients with tumors with higher risk features (7).…”
Section: Introductionmentioning
confidence: 99%
“…High-dose-rate (HDR) prostate brachytherapy in combination with external beam radiotherapy has been reported in several series with mature followup as a safe and highly effective therapy for localized adenocarcinoma of the prostate (1)(2)(3)(4)(5)(6). The outcomes of HDR brachytherapy are particularly impressive compared to outcomes of external beam radiation alone for patients with tumors with higher risk features (7).…”
Section: Introductionmentioning
confidence: 99%
“…In this case, the technique involving higher doses applied in some areas in the prostate by increasing the high-dose volume around one or more needles is called the 'boost-in-boost strategy', as it is unaffected by organ motion, PTV volume changes and setup errors [5,17,20].…”
Section: Discussionmentioning
confidence: 99%
“…In every case the prescribed dose was 10 Gy. The whole planning procedure, including needle implantation and preparation of treatment plan, was based on transrectal ultrasound (TRUS) images [8,12,16,17]. A microSelectron HDR (Nucletron B.V., Veenendaal, the Netherlands) device with iridium-192 source was used to deliver the dose [1,3,4,18].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3] Inhomogeneity corrections are typically ignored in brachytherapy dose calculations. [4][5][6] This applies to the patient as well as the applicator material.…”
Section: Introductionmentioning
confidence: 99%